Table 4.
GLM log link regression on costs per case
| Group | A = total group | B = “palliative care only” group | |||||
|---|---|---|---|---|---|---|---|
| Number of patients | n = 2151 | n = 784 | |||||
| Variable | exp(b) | (95% CI) | p-value | exp(b) | (95% CI) | p-value | |
| Location | BBM | −36.3% | (−39.2%; −33.3%) | 0.000 | −38,0% | (−42,0%; − 33,8%) | 0.000 |
| LMU | ref. | ref. | |||||
| Gender | male | −4.2% | (−7.3%; −1.0%) | 0.011 | 0,9% | (−3,0%; 4,9%) | 0.646 |
| female | ref. | ref. | |||||
| Kind of suppl. Fee for SPC | SPC for 7–13 days | 62.1% | (55.7%; 68.8%) | 0.000 | 39,4% | (17,1%; 66,0%) | 0.000 |
| SPC for 14–20 days | 79.3% | (69.7%; 89.5%) | 0.000 | 90,9% | (66,7%; 118,5%) | 0.000 | |
| SPC for ≥21 days | 69.2% | (55.3%; 84.5%) | 0.000 | 60,9% | (45,3%; 78,1%) | 0.000 | |
| SPC for 0–6 days (=no fee) | ref. | ref. | |||||
| Other suppl. Fee | no | −38.4% | (−45.3%; − 30.8%) | 0.000 | −5,8% | (−27,7%; 22,8%) | 0.659 |
| yes | ref. | ref. | |||||
| Discharge | home | 6.8% | (2.8%; 10.8%) | 0.001 | 5,7% | (1,0%; 10,7%) | 0.018 |
| to other hospital | 3.6% | (−9.0%; 17.8%) | 0.595 | 30,7% | (5,9%; 61,4%) | 0.013 | |
| to hospice | 7.5% | (1.1%; 14.4%) | 0.022 | −0,3% | (−7,7%; 7,6%) | 0.935 | |
| to nursing home | 8.5% | (−1.6%; 19.7%) | 0.101 | 6,3% | (−4,4%; 18,2%) | 0.259 | |
| other | −5.7% | (−20.0%; 11.2%) | 0.485 | −27,5% | (− 41,0%; −10,8%) | 0.002 | |
| death | ref. | ref. | |||||
| MDC | other | 4.6% | (−3.1%; 13.0%) | 0.251 | −0,2% | (−8,6%; 9,0%) | 0.973 |
| nervous system | 9.4% | (1.3%; 18.1%) | 0.022 | 7,9% | (−1,1%; 17,7%) | 0.086 | |
| respiratory system | 2.6% | (−4.8%; 10.5%) | 0.499 | 4,6% | (−3,8%; 13,9%) | 0.292 | |
| digestive system | −0.1% | (−7.4%; 7.7%) | 0.973 | 4,7% | (−4,3%; 14,4%) | 0.316 | |
| hepatobiliary system & pancreas | 3.1% | (−4.4%; 11.1%) | 0.431 | 4,2% | (−4,3%; 13,4%) | 0.348 | |
| skin, subcutaneous tissue & breast | −0.8% | (−8.6%; 7.7%) | 0.848 | 0,7% | (−8,6%; 11,1%) | 0.882 | |
| kidney and urinary tract | 1.3% | (−7.3%; 10.7%) | 0.777 | 0,9% | (−9,1%; 12,1%) | 0.861 | |
| male reproductive system | 4.4% | (−4.9%; 14.7%) | 0.367 | −3,7% | (−14,0%; 7,7%) | 0.509 | |
| female reproductive system | −0.4% | (−9.1%; 9.1%) | 0.924 | 4,2% | (−6,3%; 15,8%) | 0.452 | |
| poorly differentiated neoplasms | ref. | ref. | |||||
| Age | 0.1% | (0.0%; 0.2%) | 0.169 | 0,0% | (−0,1%; 0,2%) | 0.887 | |
| Length of stay | 5.6% | (5.3%; 6.0%) | 0.000 | 11,3% | (10,4%; 12,2%) | 0.000 | |
| No. of side diagnoses | 1.5% | (1.1%; 1.8%) | 0.000 | 1,1% | (0,6%; 1,5%) | 0.000 | |
| No. of procedure codes | 0.0% | (−0.4%; 0.5%) | 0.982 | 1,8% | (0,5%; 3,1%) | 0.008 | |
BBM (Hospital Barmherzige Brüder München), LMU (University Hospital Munich), MDC (main Diagnostic Category)
Bold numbers: significant results (α-level 0.05)